High Point, NC, United States of America

Thomas Jeffrey Clark

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Thomas Jeffrey Clark

Introduction

Thomas Jeffrey Clark is a notable inventor based in High Point, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target nicotinic cholinergic receptors. With a total of 5 patents to his name, Clark's work has the potential to impact various medical conditions and disorders.

Latest Patents

Clark's latest patents focus on pharmaceutical compositions and methods for use. One of his inventions incorporates compounds that can affect nicotinic cholinergic receptors, which are crucial for treating conditions associated with dysfunction in the central and autonomic nervous systems. Another patent relates to diazabicyclic compounds, specifically N-aryl diazabicyclic compounds. Noteworthy examples include 2-pyridinyl diazabicyclic compounds, such as (1S,4S)-2-(5-(3-methoxyphenoxy)-3-pyridyl)-2,5-diazabicyclo[2.2.1]heptane, among others. These innovations also encompass prodrug derivatives of the compounds.

Career Highlights

Clark is currently associated with Targacept, Inc., where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues for various neurological conditions.

Collaborations

Some of his notable coworkers include Balwinder Singh Bhatti and Craig Harrison Miller. Their collaborative efforts contribute to the innovative environment at Targacept, Inc.

Conclusion

Thomas Jeffrey Clark's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex biochemical interactions and hold promise for future therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…